Freenome Partners with Siemens Healthineers for Breast Cancer Research

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., Dec. 1, 2021 /PRNewswire/ -- Freenome, a privately held biotech company, announced a partnership with Siemens Healthineers to collaborate in multiomics and radiomic breast cancer diagnostics to identify suitable markers for early breast cancer detection through blood to augment existing imaging technologies....

Click to view original post